ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+55.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.7x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.18M | +58.0% |
| 2024 | $15.30M | +57.7% |
| 2023 | $9.71M | +49.9% |
| 2022 | $6.47M | +186.2% |
| 2021 | $2.26M | - |